Download presentation
Presentation is loading. Please wait.
Published byLeony Salim Modified over 6 years ago
1
A Time for Change for Managing Patients With VTE Who Have Cancer
2
Challenges of VTE in Cancer
3
Hokusai VTE-Cancer
4
Hokusai-VTE Cancer: Study Design
5
Hokusai VTE-Cancer: Clinical Outcomes
6
Hokusai VTE-Cancer: Types of Major Bleeds Contributing to Primary Outcome
7
Hokusai VTE-Cancer: Duration of Study Drug Treatment
8
Hokusai VTE-Cancer: Reasons for Study Drug Discontinuation
9
US Prescription Patterns for Cancer-Associated VTE
10
Potential Clinical Implications of Hokusai VTE-Cancer Study
11
Hokusai VTE-Cancer
12
Clinical Value of Composite Endpoint in Hokusai VTE-Cancer
13
Interpretation of Clinical Outcomes
14
GI Bleeding
15
Treatment and Secondary Prevention Strategy for VTE in Patients With Active Cancer
16
Hokusai VTE-Cancer
17
Relevance of NOACs in Cancer-Associated VTE
18
Efficacy and Safety of NOACs in Cancer vs No Cancer
19
Addressing the Use of NOACs in Patients With Cancer
20
Limitations of Managing VTE in South America
21
Strengths and Limitations of Hokusai VTE-Cancer
22
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.